Cargando…

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients

Detalles Bibliográficos
Autores principales:	Mohr-Holland, E., Daniels, J., Douglas-Jones, B., Mema, N., Scott, V., Trivino-Duran, L., Pfaff, C., Furin, J., Isaakidis, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union Against Tuberculosis and Lung Disease 2021
Materias:	Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091908/ https://www.ncbi.nlm.nih.gov/pubmed/33977912 http://dx.doi.org/10.5588/ijtld.21.0010

Ejemplares similares

Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era
por: Zokufa, N., et al.
Publicado: (2021)

Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
por: Mohr-Holland, E., et al.
Publicado: (2021)

Early mortality during rifampicin-resistant TB treatment
por: Mohr-Holland, E., et al.
Publicado: (2022)

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
por: Cates, L., et al.
Publicado: (2021)

How COVID-19 could benefit tuberculosis and HIV services in South Africa
por: Keene, Claire, et al.
Publicado: (2020)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

Criminal Justice Reform as HIV and TB Prevention in African Prisons
por: Todrys, Katherine W., et al.
Publicado: (2012)

Current state of national TB laboratory networks in Europe: achievements and challenges
por: Klaos, K., et al.
Publicado: (2022)

The effects of MDR/RR-TB treatment on HIV disease: A systematic review of literature
por: Geiger, Keri, et al.
Publicado: (2021)

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa
por: Mohr-Holland, Erika, et al.
Publicado: (2020)

What Research Is Needed to Stop TB? Introducing the TB Research Movement
por: Lienhardt, Christian, et al.
Publicado: (2011)

Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household
por: Apolisi, Ivy, et al.
Publicado: (2023)

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic
por: Mohr-Holland, Erika, et al.
Publicado: (2021)

HIV testing during the neonatal period
por: Sherman, Gayle G.
Publicado: (2015)

Towards quality adolescent-friendly services in TB care
por: Laycock, K. M., et al.
Publicado: (2021)

Active case-finding for TB among incarcerated women in Peru
por: Puma, D., et al.
Publicado: (2023)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

Costs of treating multidrug-resistant TB in California in 2022
por: Katrak, S., et al.
Publicado: (2023)

Diagnosis and Treatment Pathway of MDR/RR-TB in Taizhou, Zhejiang Province, China
por: Lu, Jingting, et al.
Publicado: (2023)

HIV testing and antiretroviral therapy initiation at birth: Views from a primary care setting in Khayelitsha
por: Nelson, Aurélie, et al.
Publicado: (2015)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

Euro Conditionality Hinges on Positive Convergence
por: Marcussen, Michala
Publicado: (2022)

TB testing in HIV-positive patients prior to antiretroviral treatment
por: Spooner, E., et al.
Publicado: (2022)

High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia
por: Akalu, Gizachew Taddesse, et al.
Publicado: (2022)

Research gaps in neonatal HIV-related care
por: Davies, Mary-Ann
Publicado: (2015)

HIV Testing for Children in Resource-Limited Settings: What Are We Waiting For?
por: Kellerman, Scott, et al.
Publicado: (2010)

Recognising and managing increased HIV transmission risk in newborns
por: Kroon, Max
Publicado: (2015)

DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting
por: Mohr, Erika, et al.
Publicado: (2017)

Recognizing and managing sepsis: what needs to be done?
por: Yealy, Donald M, et al.
Publicado: (2015)

RR photons
por: Camara, Pablo G., et al.
Publicado: (2011)

Breastfeeding and the 2015 South African guidelines for prevention of mother-to-child transmission of HIV
por: Kuhn, Louise, et al.
Publicado: (2015)

A Transformative Vision for an Omics-Based Regulatory Chemical Testing Paradigm
por: Johnson, Kamin J, et al.
Publicado: (2022)

CAM photosynthesis: the acid test
por: Winter, Klaus, et al.
Publicado: (2021)

Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework
por: Thomas, Russell S., et al.
Publicado: (2013)

Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy
por: McNairy, Margaret L., et al.
Publicado: (2017)

Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012–2020 Period Analysis
por: Lecai, Ji, et al.
Publicado: (2021)

Response to Invited Commentary “Undoubtedly, kidney transplant recipients have a higher mortality due to COVID‐19 disease compared to the general population”
por: Hugo, Christian, et al.
Publicado: (2021)

Shielding Studies for RR13/17 and RR53/57 Areas
por: Kwee, R, et al.
Publicado: (2012)

The Limitations of Evidence
por: Black, Douglas
Publicado: (1998)

A Black Look at the Independent Inquiry into Inequalities in Health
por: Black, Douglas
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_vkjf121pgg0nt9skrt5dltqmt3